Podiatrists in Payson, UT Accepting Medicare
5 Podiatrists found. Showing 1 - 5
 Summit Foot And Ankle Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 41 N 400 W Ste A, Payson, UT 84651 Phone: 801-218-3338 Fax: 801-658-5351 |
 Dr. Brant Matthew Burnham, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 828 S 1040 W, Payson, UT 84651 Phone: 801-980-9444 Fax: 801-224-5204 |
Dr. Jesse Ellsworth Riley, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 41 N 400 W Ste A, Payson, UT 84651 Phone: 801-218-3338 Fax: 801-658-5351 |
Family Foot And Ankle Specialists Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 828 S 1040 W, Payson, UT 84651 Phone: 801-980-9444 Fax: 801-224-5204 |
David T Savage, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 E 100 N #2, Payson, UT 84651 Phone: 801-465-1345 Fax: 801-465-1354 |
News Archive
CivaTech Oncology receives NIH/NCI Phase II Contract for CivaSheet device to treat NSCLC
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
Europe is the main source of COVID-19 spread, shows study
The University of Huddersfield's Archaeogenetics Research Group has mapped out the dispersal of the SARS-CoV-2 coronavirus, responsible for the current worldwide COVID-19 pandemic, putting Europe centre-stage as the main source of the spread.
Health law's insurance exchanges studied, demonstrated
According to data from Connecticut insurers, the majority of health plans sold to individuals and small businesses provide less generous coverage - most likely, at a lower cost - than plans sold on the exchange will be required to provide. The analysis suggests that people buying insurance through the exchange could get plans that offer more coverage with lower out-of-pocket costs, but they would likely have to pay more for them.
Pivotal PROPEL trial data of FOLOTYN in patients with refractory PTCL reported at ASH Annual Meeting
Allos Therapeutics, Inc. today reported new analyses of data from the Company's pivotal PROPEL trial of FOLOTYN (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma at the 52nd American Society of Hematology Annual Meeting held in Orlando, Florida.
Enterovirus 71 in China claims the lives of two more children
The World Health Organisation (WHO) has warned that a virus that has killed 24 young children and infected more than 5,000 could continue to spread regardless of efforts to contain it.
› Verified 3 days ago
Chiropractors
Physical Therapists
Occupational Therapists
Podiatrists
Speech-Language Pathologists
Optometrists
Audiologists